Growth Metrics

Healthequity (HQY) Cash from Investing Activities (2016 - 2026)

Healthequity has reported Cash from Investing Activities over the past 14 years, most recently at -$8.4 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 37.77% year-over-year to -$8.4 million; the TTM value through Jan 2026 reached -$47.1 million, up 90.67%, while the annual FY2026 figure was -$47.1 million, 90.67% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$8.4 million at Healthequity, up from -$11.4 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$8.4 million in Q1 2026 and troughed at -$471.3 million in Q1 2022.
  • A 5-year average of -$69.9 million and a median of -$13.5 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 97.82% in 2023 and later crashed 2855.12% in 2024.
  • Year by year, Cash from Investing Activities stood at -$13.5 million in 2022, then decreased by 13.99% to -$15.4 million in 2023, then rose by 16.57% to -$12.9 million in 2024, then rose by 11.54% to -$11.4 million in 2025, then increased by 25.88% to -$8.4 million in 2026.
  • Business Quant data shows Cash from Investing Activities for HQY at -$8.4 million in Q1 2026, -$11.4 million in Q4 2025, and -$11.2 million in Q3 2025.